Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지

Reduced Tumor Lysis Syndrome with Low Dose Chemotherapy for Hyperleukocytic Acute Leukemia prior to Induction Therapy

Liang, Rong;Bai, Qing-Xian;Zhang, Yong-Qing;Zhang, Tao;Yang, Lan;Wang, Yi-Wei;Zhu, Hua-Feng;Wang, Wen-Qing;Gu, Hong-Tao;Gao, Guang-Xun;Shu, Mi-Mi;Chen, Xie-Quan

  • Published : 20110700
⟨ Previous Next ⟩

Abstract

Patients with hyperleukocytic acute leukemia (HAL) can succumb to leukostasis. In an attempt to reduce its incidence, 45 patients with newly diagnosed HAL and hyperleukocytosis were administered half the conventional dose of etoposide and cytosine arabinoside (EA: 50mg/m2 daily each) until WBC counts were significantly reduced and standard induction therapy was initiated. We retrospectively reviewed their outcomes and analyzed potential factors with a logistic regression model. The incidence of early mortality (<30days) was 4.4% (2/45). Patients who achieved complete remission with induction chemotherapy had significantly lower median WBC counts ($26{\times}10^9$ L-1) after low dose EA treatment than the no response patients (median WBC: $65{\times}10^9$ L-1 (P<0.05). Low dose EA treatment of HAL patients reduced WBC for both lymphoid and myeloid leukemic cells and can be considered for preemptive administration to HAL patients prior to the differential diagnosis of the acute leukemia. This approach warrants further studies as a cytoreduction therapy for HAL.

Keywords

References

  1. Apostolidou E, Swords R, Alvarado Y, Giles FJ (2007). Treatment of acute lymphoblastic leukaemia : a new era. Drugs, 67, 2153-71. https://doi.org/10.2165/00003495-200767150-00004
  2. Chang MC, Chen TY, Tang JL, et al (2007). Leukapheresis and cranial irradiation in patients with hyperleukocytic acute myeloid leukemia: no impact on early mortality and intracranial hemorrhage. Am J Hematol, 82, 976-80. https://doi.org/10.1002/ajh.20939
  3. Creutzig U, Buchner T, Sauerland MC, et al (2008). Significance of age in acute myeloid leukemia patients younger than 30 years: a common analysis of the pediatric trials AML-BFM 93/98 and the adult trials AMLCG 92/99 and AMLSG HD93/98A. Cancer, 112, 562-71. https://doi.org/10.1002/cncr.23220
  4. Greenwood MJ, Seftel MD, Richardson C, et al (2006). Leukocyte count as a predictor of death during remission induction in acute myeloid leukemia. Leuk Lymphoma, 47, 1245-52. https://doi.org/10.1080/10428190600572673
  5. Griffin TC, Weitzman S, Weinstein H, et al (2009). A study of rituximab and ifosfamide, carboplatin, and etoposide chemotherapy in children with recurrent/refractory B-cell (CD20+) non-Hodgkin lymphoma and mature B-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group. Pediatr Blood Cancer, 52, 177-81. https://doi.org/10.1002/pbc.21753
  6. Haase R, Merkel N, Diwan O, Elsner K, Kramm CM (2009). Leukapheresis and exchange transfusion in children with acute leukemia and hyperleukocytosis. A single center experience. Klin Pediatr, 221, 374-8. https://doi.org/10.1055/s-0029-1239533
  7. Inaba H, Fan Y, Pounds S, et al (2008). Clinical and biologic features and treatment outcome of children with newly diagnosed acute myeloid leukemia and hyperleukocytosis. Cancer, 113, 522-9. https://doi.org/10.1002/cncr.23581
  8. Marbello L, Ricci F, Nosari AM, et al (2008). Outcome of hyperleukocytic adult acute myeloid leukaemia: a singlecenter retrospective study and review of literature. Leuk Res, 32, 1221-7. https://doi.org/10.1016/j.leukres.2008.01.004
  9. Nau KC, Lewis WD (2008). Multiple myeloma: diagnosis and treatment. Am Fam Physician, 78, 853-9.
  10. Oliveira LC, Romano LG, Prado-Junior BP, et al (2010). Outcome of acute myeloid leukemia patients with hyperleukocytosis in Brazil. Med Oncol, 27, 1254-9. https://doi.org/10.1007/s12032-009-9367-9
  11. Ozdemir MA, Karakukcu M, Patiroglu T, Torun YA, Kose M (2009). Management of hyperleukocytosis and prevention of tumor lysis syndrome with low-dose prednisone continuous infusion in children with acute lymphoblastic leukemia. Acta Haematol, 121, 56-62. https://doi.org/10.1159/000210392
  12. Ruggiero A, Attina G, Piastra M, et al (2009). Severe hyperleukocytosis and multifocal intracranial haemorrhage: not always a fatal outcome. Int J Hematol, 90, 87-90. https://doi.org/10.1007/s12185-009-0333-2
  13. Wald BR, Heisel MA, Ortega JA (1982). Frequency of early death in children with acute leukemia presenting with hyperleukocytosis. Cancer, 50, 150-3. https://doi.org/10.1002/1097-0142(19820701)50:1<150::AID-CNCR2820500128>3.0.CO;2-A
  14. Wang X, Lin G, Wang J (1997). 244 patients with hyperleukocytic acute leukemia. Shanghai Leukemia Cooperation Group. Chin J Int Med, 36, 532-5 (in Chinese).